Skip to main content
. 2022 Jun 30;14(7):1443. doi: 10.3390/v14071443

Table 1.

Characteristics of the COVID-19 convalescent plasma donors.

CCP
Donorno.		 Sex Age
(Years)		 CCP Donation
(m/d/y)		 COVID-19 Vaccine Anti-SARS-CoV-2 nAb Titer Days between CCP Donation and VOC
Lineage
Type Doses Last Dose
(Month/Day/Year)		 Anti-Wild
Type		 Anti-
B.1.617.2		 Anti-
B.1.1.529		 Last Vaccine Dose COVID-19
Recovery
1 M 53 10/06/2021 AZ 2 06/09/2021 640 320 10 119 13 B.1.617.2
2 M 56 10/20/2021 AZ 1 05/15/2021 640 80 <10 158 89 B.1.617.2
3 M 27 10/27/2021 AZ 2 05/15/2021 640 160 10 165 141 B.1.617.2
4 F 35 10/27/2021 Pfizer 1 06/26/2021 160 40 <10 123 70 B.1.617.2
5 M 46 10/27/2021 J&J 1 06/06/2021 640 160 10 143 19 B.1.617.2
6 M 20 11/10/2021 Pfizer 1 06/20/2021 320 160 10 143 82 B.1.617.2
7 F 52 11/10/2021 Pfizer 2 03/10/2021 640 320 40 245 71 B.1.617.2
8 M 35 11/17/2021 Pfizer 1 02/02/2021 640 640 40 288 54 B.1.617.2
9 M 53 11/24/2021 AZ 1 06/07/2021 20 1 10 1 10 1 170 91 B.1.617.2
10 M 58 12/01/2021 Pfizer 2 07/06/2021 160 80 <10 148 20 B.1.617.2
11 M 46 12/10/2021 Pfizer 2 07/18/2021 320 160 10 145 21 B.1.617.2
12 M 51 12/10/2021 J&J 1 06/07/2021 640 320 20 186 35 B.1.617.2
13 M 28 12/15/2021 AZ 2 05/31/2021 320 640 40 198 23 B.1.617.2
14 M 53 12/16/2021 AZ 2 06/09/2021 640 160 10 190 84 B.1.617.2
15 M 26 12/22/2021 J&J 1 06/30/2021 640 640 40 175 27 B.1.617.2
16 F 47 12/27/2021 Pfizer 2 06/10/2021 NP 320 40 200 14 B.1.617.2
17 M 51 12/27/2021 AZ 2 06/09/2021 NP 640 160 201 26 B.1.617.2
19 M 26 01/05/2022 Pfizer 2 08/05/2021 NP 640 10 153 21 B.1.617.2
19 M 59 01/05/2022 Pfizer 2 06/26/2021 NP 640 <10 193 149 B.1.617.2
20 M 40 02/08/2022 Pfizer 2 10/29/2021 NP 640 160 105 22 B.1.1.529
21 M 57 02/08/2022 Pfizer 3 10/26/2021 NP 640 320 102 18 B.1.1.529
22 M 57 02/11/2022 Pfizer (2)/AZ (1) 3 11/29/2021 NP 640 640 74 36 B.1.1.529
23 M 56 02/16/2022 Pfizer (2)/Moderna (1) 3 12/18/2021 NP 640 160 60 21 B.1.1.529
24 M 55 02/17/2022 Pfizer (2)/AZ (1) 3 12/03/2021 NP 320 40 76 22 B.1.1.529
25 M 56 02/18/2022 Pfizer (2)/AZ (1) 3 01/20/2022 NP 160 80 29 18 B.1.1.529
26 M 34 02/21/2022 Pfizer (2)/Moderna (1) 3 01/12/2022 NP 640 160 40 19 B.1.1.529
27 M 51 02/24/2022 J&J (1)/Moderna (2) 3 12/23/2021 NP 320 160 63 32 B.1.1.529
28 M 40 03/11/2022 Pfizer 3 07/17/2021 NP 160 20 237 24 B.1.1.529
29 M 24 03/15/2022 Pfizer (2)/Moderna (1) 3 01/13/2022 NP 160 160 61 45 B.1.1.529
30 M 34 03/22/2022 Pfizer (2)/Moderna (1) 3 12/16/2021 NP 640 160 96 17 B.1.1.529
31 M 54 03/23/2022 Pfizer (2)/Moderna (1) 3 01/07/2022 NP 640 320 75 13 B.1.1.529
32 M 38 03/25/2022 Pfizer (2)/Moderna (1) 3 01/21/2022 NP 640 640 63 52 B.1.1.529

Abbreviations: CCP, COVID-19 convalescent plasma; AZ, AstraZeneca; J&J, Janssen-Johnson & Johnson; NP, not performed; VOC, variant of concern. 1 Unit from donor 9 was not qualified as CCP due to insufficient neutralizing antibody activity (<160 to all VOCs).